Virus blood tests showed past exposure in Brazilian MS
By MS Buddy ·
Summarized from Journal of the neurological sciences, Nov 2026 · PubMed. AI-generated summary. Not medical advice.
Observational study · 70 people with MS at a neurological center in Brazil
Research by Juliana Santiago-Amaral, Fernanda Ludolf and 6 colleagues at Instituto de Previdência dos Servidores do Estado de Minas Gerais and Universidade Federal de Minas Gerais in Brazil.
What did viral blood tests find in people with MS at a Brazilian center?
Key Takeaway
Blood tests often found signs of past viral exposure in people with MS at a Brazilian center.

What They Found
Researchers reviewed routine blood tests for 70 people with MS in Brazil. About 95% of those tested had signs of past exposure to Epstein-Barr virus or rubella. About 88% had signs of past exposure to the viruses that cause chickenpox or a common infection called cytomegalovirus. About 45% tested positive for a hepatitis B marker, while no one tested positive for several other viruses. Viral test results did not clearly differ by MS treatment or recent treatment given through a vein.
Who Should Care and Why
The study included people with MS treated at one neurological center in Brazil. It describes the viral blood test results found in their routine care. These tests can help doctors review vaccination plans and treatment choices. The researchers also compared results across MS treatments and recent treatment given through a vein. Those comparisons were exploratory, so the study does not settle whether treatment changes viral test results.
Important Considerations
You should know this was a review of records for 70 people, not a trial. Not everyone had every viral test, so the results come from different-sized groups. You cannot tell from this study whether MS treatments caused any differences in viral test results.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Journal of the neurological sciences by et al.. Reproduced from the PubMed record.
Defining viral serology in multiple sclerosis (MS) patients has become increasingly more relevant, given the potential association between viruses and MS, along with the recent introduction of new immunosuppressive treatments. To describe the frequency of viral seropositivity in a Brazilian cohort of patients with MS and to explore the association of disease-modifying therapies (DMTs) and intravenous pulse therapy (IVPT) with viral serological status. This retrospective descriptive study evaluated the seropositivity of ten viral markers in 70 patients with MS followed by a specialist at a neurological center in Brazil. Serological testing was performed according to routine clinical practice; therefore, not all patients were tested for every viral marker. High frequence of IgG seropositivity was observed for Epstein-Barr virus (95.1%), rubella (95.7%), varicella-zoster virus (87.5%), and cytomegalovirus (87.2%). Anti-HBs positivity was detected in 45.2% of patients, whereas no cases of HBsAg, HIV, HCV, or HTLV-I/II were identified. IgM positivity was uncommon. No statistically significant differences in viral seropositivity were detected according to DMT or recent IVPT exposure. This study describes the viral serological profile of a Brazilian cohort of patients with MS and supports the clinical value of baseline viral screening for vaccination planning and treatment evaluation. The analyses according to DMT and a recent IVPT exposure should be considered exploratory, and prospective studies with standardized viral screening are needed to better define the impact of these therapies on viral serological status.
Categories
Explore more research
Related MS research

11/18/2026
An adjusted MRI scan found more veins within MS brain lesions in 17 people with MS. It improved scan
Read More
1/1/2026
After a car crash, brain and spine scans revealed signs of MS in an 18-year-old male. Further tests
Read More
11/14/2026
An opinion paper explains why MS brain scans can show tissue loss without proving nerve signal failu
Read More
11/12/2026
In a study of 601 people in Japan after first optic nerve inflammation, some later had MS. Others ha
Read More
11/12/2026
A new way to analyze brain scans generally predicted thinking test scores in people with MS better t
Read More
11/11/2026
Brain scans of people with low-disability MS showed subtle differences from scans of people without
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
